Muscarinic receptor Agonists: examples, action/effect
pilocarpine, bethanechol
↑ SLUDD
Muscarinic receptor Antagonists: examples, action/effect
atropine, oxybutynin
↓ SLUDD
Nicotinic receptor Agonists: examples, action/effect
nicotine
↑ HR, BP
Nicotinic receptor Antagonists: examples, action/effect
neuromuscular blockers (e.g., rocuronium)
causes neuromuscular blockade
Alpha-1 receptor Agonists: examples, action/effect
phenylephrine, dopamine
smooth muscle vasoconstriction, ↑ BP
Alpha-1 receptor Antagonists: examples, action/effect
doxazosin, carvedilol, phentolamine
smooth muscle vasodilation, ↓ BP
Alpha-2 receptor Agonists: examples, action/effect
clonidine, brimonidine (ophthalmic)
↓ release of epinephrine and NE, ↓ BP, HR
Alpha-2 receptor Antagonists: examples, action/effect
ergot alkaloids, yohimbine
↑ BP, HR
Beta-1 receptor Agonists: examples, action/effect
dobutamine, isoproterenol, dopamine
↑ myocardial contractility, CO, HR
Beta-1 receptor Antagonists: examples, action/effect
beta-1 selective blockers (atenolol, esmolol, metoprolol)
non-selective beta blockers (propranolol, carvedilol, labetalol, nadolol)
↓ CO, HR
Beta-2 receptor Agonists: examples, action/effect
albuterol, terbutaline, isoproterenol
bronchodilation
Beta-2 receptor Antagonists: examples, action/effect
non-selective beta blockers (propranolol, carvedilol, labetalol, nadolol)
bronchoconstriction
Dopamine receptor Agonists: examples, action/effect
levodopa, pramipexole
many, including renal, cardiac, CNS
Dopamine receptor Antagonists: examples, action/effect
1st-gen antipsychotics, metoclopramide
many, including renal, cardiac, CNS
Serotonin receptor Agonists: examples, action/effect
triptans (e.g., sumatriptan)
many, including platelet, GI, psychiatric
Serotonin receptor Antagonists: examples, action/effect
ondansetron, 2nd-gen antipsychotics
many, including platelet, GI, psychiatric
Acetylcholinesterase inhibitors, and drug action
donepezil, rivastigmine, galantamine
blocks acetylcholinesterase, resulting in ↑ ACh levels; used for Alzheimer’s
ACE inhibitors, and drug action
-pril
inhibit conversion of angiotensin I to II, resulting in ↓ vasoconstriction and ↓ aldosterone secretion
COMT inhibitors, and drug action
entacapone
prevents breakdown of levodopa, resulting in ↑ duration of action of levodopa; used for Parkinson’s
COX inhibitors, and drug action
NSAIDs
↓ prostaglandins and thromboxane A2
MAO inhibitors, and drug action
phenelzine, isocarboxazid, tranylcypromine, selegiline, rasagiline
↓ catecholamine levels
Phosphodiesterase (PDE) inhibitors, and drug action
sildenafil, tadalafil
competitively bind to same active site as cGMP on the PDE-5 enzyme, preventing cGMP breakdown and prolonging smooth muscle relaxation
Vitamin K epoxide reductase inhibitor, and drug action
warfarin
↓ production of clotting factors II, VII, IX, and X
Xanthine oxidase inhibitor, and drug action
allopurinol
↓ uric acid production; used for gout attacks